TG Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 65,476.7% | 207,295,256.6% | 72,673.6% | 74,660.7% | 82,953.6% | 81,512.0% | 109,460.5% | 116,742.1% | 90,376.3% | 0.0% | – | – | – | 444,881.6% | – | – | – | 278.9% | 17.5% | 9.6% | 14.4% | 9.0% | 11.8% | 3.9% | 2.1% | 3.8% | 11.0% | 11.9% | 2.1% | 18.1% | 8.7% | 11.3% | 11.1% | 14.2% | 12.9% | 13.4% | 17.4% | 19.8% | 16.4% | 17.1% | 17.6% | |
| 100.0% | -207,295,156.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -444,781.6% | 100.0% | 100.0% | 100.0% | -178.9% | 82.5% | 90.4% | 85.6% | 91.0% | 88.2% | 96.1% | 97.9% | 96.3% | 89.0% | 88.1% | 97.9% | 81.9% | 91.3% | 88.7% | 88.9% | 85.8% | 87.1% | 86.6% | 82.6% | 80.2% | 83.6% | 82.9% | 82.4% | |
| 54,803.9% | 56,214.0% | 53,486.8% | 66,779.0% | 66,502.4% | 67,557.7% | 84,628.9% | 99,505.3% | 86,194.7% | 134,392.1% | 81,305.3% | 82,931.6% | 148,692.1% | 77,510.5% | 94,794.7% | 95,918.4% | 132,800.0% | 113,055.3% | 7,956.4% | 2,904.3% | 2,560.0% | 2,699.1% | 2,383.0% | 4,524.2% | 22,128.7% | 37,043.8% | 203.4% | 139.7% | 8.9% | 39.7% | 51.6% | 23.9% | 24.0% | 22.1% | 38.4% | 22.5% | 25.3% | 21.4% | 23.6% | 39.7% | 28.2% | |
| 8,310.1% | 4,679.9% | 13,182.8% | 4,612.2% | 11,744.0% | 13,326.5% | 17,360.5% | 14,955.3% | 2,547.4% | 5,031.6% | 10,081.6% | 10,705.3% | 11,568.4% | 22,484.2% | 37,528.9% | 37,984.2% | 92,884.2% | 130,710.5% | 3,374.8% | 2,201.7% | 1,719.2% | 1,396.5% | 1,022.3% | 2,127.6% | 15,163.8% | 28,130.0% | 359.7% | 226.3% | 19.8% | 77.3% | 54.5% | 52.8% | 50.0% | 36.0% | 41.6% | 39.4% | 39.2% | 32.6% | 43.0% | 34.2% | 37.1% | |
| 65,528.1% | 63,174.0% | 72,724.8% | 74,717.1% | 83,009.6% | 81,566.7% | 109,513.2% | 116,797.4% | 90,436.8% | 142,600.0% | 91,386.8% | 93,636.8% | 160,260.5% | 99,994.7% | 132,323.7% | 133,902.6% | 225,684.2% | 228,194.7% | 11,331.1% | 5,106.1% | 4,279.1% | 4,095.6% | 3,405.3% | 6,651.9% | 37,292.6% | 65,173.7% | 563.1% | 366.0% | 28.7% | 110.3% | 105.9% | 76.7% | 74.0% | 58.1% | 80.0% | 61.9% | 64.4% | 54.0% | 66.7% | 73.8% | 65.3% | |
| -65,428.1% | -63,074.0% | -72,624.8% | -74,617.1% | -82,909.6% | -81,466.7% | -109,413.2% | -116,697.4% | -90,336.8% | -142,500.0% | -91,286.8% | -93,536.8% | -160,160.5% | -99,894.7% | -132,223.7% | -133,802.6% | -225,584.2% | -228,373.7% | -11,248.7% | -5,015.7% | -4,193.5% | -4,004.6% | -3,317.1% | -6,555.7% | -37,194.7% | -65,077.5% | -474.1% | -277.9% | 69.2% | -28.4% | -14.6% | 12.0% | 14.8% | 27.7% | 7.1% | 24.7% | 18.2% | 26.2% | 17.0% | 9.0% | 17.1% | |
| 555.3% | 1,771.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 586.8% | 581.6% | 2,834.2% | 2,036.8% | 2,834.2% | 4,044.7% | 4,997.4% | 3,160.5% | 5,863.2% | 4,236.8% | 3,397.4% | 239.3% | 105.0% | 51.1% | 46.5% | 132.1% | 507.9% | 1,753.2% | 3,577.5% | 36.4% | 22.6% | 2.2% | 5.5% | 3.6% | 5.4% | 12.9% | 6.5% | 5.6% | 4.8% | 4.2% | 3.4% | 3.7% | 6.9% | 4.7% | |
| -65,180.1% | -62,145.0% | -72,785.2% | -74,427.3% | -82,779.4% | -81,007.4% | -109,286.8% | -116,163.2% | -89,344.7% | -141,736.8% | -92,515.8% | -95,297.4% | -162,973.7% | -104,134.2% | -134,515.8% | -139,168.4% | -229,376.3% | -232,152.6% | -11,428.5% | -5,080.6% | -4,218.6% | -4,021.5% | -3,423.3% | -6,819.9% | -38,104.3% | -66,242.5% | -502.8% | -296.2% | 68.7% | -31.9% | -16.8% | 8.9% | 5.1% | 23.5% | 4.5% | 21.9% | 16.0% | 23.4% | 9.9% | 4.3% | 12.7% | |
| -247.9% | -929.0% | 160.4% | -189.8% | -130.1% | -459.3% | -126.3% | -534.2% | -992.1% | -763.2% | 1,228.9% | 1,760.5% | 2,813.2% | 4,239.5% | 2,292.1% | 5,365.8% | 3,792.1% | 3,778.9% | 179.8% | 65.1% | 25.1% | 16.8% | 106.2% | 264.1% | 909.6% | 1,162.5% | -7.7% | 22.6% | -0.1% | 0.9% | 0.0% | -0.4% | 0.5% | 2.0% | 0.3% | 1.9% | -225.7% | 11.5% | 0.3% | 1.0% | -42.5% | |
| -65,180.1% | -62,145.0% | -72,785.2% | -74,427.3% | -82,779.4% | -81,007.4% | -109,286.8% | -116,163.2% | -89,344.7% | -141,736.8% | -92,515.8% | -95,297.4% | -162,973.7% | -104,134.2% | -134,515.8% | -139,168.4% | -229,376.3% | -232,152.6% | -11,428.5% | -5,080.7% | -4,218.6% | -4,021.5% | -3,423.3% | -6,819.9% | -38,104.3% | -66,242.5% | -502.8% | -296.2% | 68.7% | -32.8% | -16.9% | 9.4% | 4.6% | 21.6% | 4.2% | 20.0% | 241.7% | 12.0% | 9.7% | 3.2% | 55.2% | |
| -65,377.8% | -61,536.3% | -72,571.2% | -74,561.0% | -82,853.8% | -81,414.9% | -109,360.5% | -116,107.9% | -89,284.2% | -142,436.8% | -91,226.3% | -92,402.6% | -158,860.5% | -98,947.4% | -131,134.2% | -133,068.4% | -224,892.1% | -228,476.3% | -11,175.0% | -4,967.8% | -4,161.1% | -3,969.2% | -3,284.7% | -6,289.9% | -36,213.8% | -62,507.5% | -464.8% | -273.1% | 71.0% | -26.2% | -13.1% | 14.4% | 18.1% | 30.1% | 10.2% | 26.7% | 20.2% | 26.8% | 13.7% | 9.0% | 16.8% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.